{"id":9616,"date":"2026-05-01T10:26:59","date_gmt":"2026-05-01T15:26:59","guid":{"rendered":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/"},"modified":"2026-05-01T10:26:59","modified_gmt":"2026-05-01T15:26:59","slug":"more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2","status":"publish","type":"post","link":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/","title":{"rendered":"More states consider dropping GLP-1 weight loss drugs from Medicaid"},"content":{"rendered":"<figure><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/missouriindependent.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"A woman takes out an Ozempic pen. More states are considering dropping GLP-1 drugs from their Medicaid programs. (Photo by Shalina Chatlani\/Stateline)\" \/><figcaption>\n<p>A woman takes out an Ozempic pen. More states are considering dropping GLP-1 drugs from their Medicaid programs. (Photo by Shalina Chatlani\/Stateline)<\/p>\n<\/figcaption><\/figure>\n<p><span>Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications.\u00a0<\/span><\/p>\n<p><span>Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.\u00a0<\/span><\/p>\n<p><span>Medicaid programs in California, New Hampshire, Pennsylvania and South Carolina have eliminated coverage of the drugs for weight loss, because the expense strained state budgets.\u00a0<\/span><\/p>\n<p><span>In Massachusetts, the governor\u2019s proposed fiscal 2028 budget would not fund the state\u2019s Medicaid program, MassHealth, to cover GLP-1 medications for weight loss alone, though the state would continue covering the drugs for diabetes and other conditions. The legislature is still debating the state budget.\u00a0<\/span><\/p>\n<p><span>Rhode Island<\/span><span>\u2019s governor <\/span><a href=\"https:\/\/rhodeislandcurrent.com\/2025\/10\/10\/rhode-island-considers-ending-medicaid-coverage-of-glp-1-drugs-for-weight-loss\/\" target=\"_blank\"><span>also has proposed<\/span><\/a><span> removing GLP-1 coverage from the state\u2019s Medicaid program for weight loss treatment.\u00a0<\/span><\/p>\n<p><span>North Carolina reinstated such coverage in mid-December after having dropped it in October.\u00a0<\/span><\/p>\n<p><span>Medicaid programs in Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, Tennessee, Utah, Virginia and Wisconsin also <\/span><a href=\"https:\/\/www.kff.org\/medicaid\/medicaid-coverage-of-and-spending-on-glp-1s\/\" target=\"_blank\"><span>cover<\/span><\/a><span> the drugs for obesity treatment, according to KFF, a health policy research group.\u00a0<\/span><\/p>\n<p><span>But some states, such as Michigan, have restricted eligibility for these medications to morbidly obesity patients rather than those who are overweight or obese. The move is expected to save the state an estimated $240 million.\u00a0<\/span><\/p>\n<p><span>Meanwhile, <\/span><a href=\"https:\/\/lailluminator.com\/2026\/04\/16\/louisiana-medicaid-might-add-coverage-for-popular-obesity-treatment-drugs\/\" target=\"_blank\"><span>lawmakers<\/span><\/a><span> in Louisiana are debating whether to allow Medicaid to cover GLP-1s for obesity treatment if enrollees have another chronic condition, or comorbidity, such as prediabetes, hypertension or cardiovascular disease.\u00a0\u00a0<\/span><\/p>\n<p><span>The medications generally have been too expensive for people without insurance. In February, one of the largest producers of these drugs, Novo Nordisk, announced it would reduce their list prices to $675 per month in 2027.\u00a0<\/span><\/p>\n<p><span>Gross spending on Medicaid prescriptions for GLP-1s \u2014 for diabetes as well as for weight loss \u2014 has increased from around $1 billion in 2019 to almost $9 billion in 2024 as demand for these drugs has risen, according to <\/span><a href=\"https:\/\/www.kff.org\/medicaid\/medicaid-coverage-of-and-spending-on-glp-1s\/\" target=\"_blank\"><span>KFF<\/span><\/a><span>.\u00a0<\/span><\/p>\n<p><span>At the same time almost 40% of adults and a quarter of children with Medicaid have obesity and may benefit from having access to the drugs, according to KFF.\u00a0<\/span><\/p>\n<p><i><span>Stateline reporter Shalina Chatlani can be reached at <\/span><\/i><a href=\"mailto:schatlani@stateline.org\"><i><span>schatlani@stateline.org<\/span><\/i><\/a><i><span>.<\/span><\/i><\/p>\n<div class=\"snrPubNote\">\n<p>This story was originally produced by <a href=\"https:\/\/stateline.org\/2026\/04\/30\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid\/\" target=\"_blank\">Stateline<\/a>, which is part of States Newsroom, a nonprofit news network which includes Missouri Independent, and is supported by grants and a coalition of donors as a 501c(3) public charity.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>A woman takes out an Ozempic pen. More states are considering dropping GLP-1 drugs from their Medicaid programs. (Photo by Shalina Chatlani\/Stateline) Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications.\u00a0 Thirteen state Medicaid programs&#8230;<\/p>\n","protected":false},"author":2,"featured_media":9617,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com\" \/>\n<meta property=\"og:description\" content=\"A woman takes out an Ozempic pen. More states are considering dropping GLP-1 drugs from their Medicaid programs. (Photo by Shalina Chatlani\/Stateline) Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications.\u00a0 Thirteen state Medicaid programs...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/\" \/>\n<meta property=\"og:site_name\" content=\"WestplexNews.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-01T15:26:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/missouriindependent.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1.jpg\" \/>\n<meta name=\"author\" content=\"Brad Hildebrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brad Hildebrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/\"},\"author\":{\"name\":\"Brad Hildebrand\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#\\\/schema\\\/person\\\/86ac6e2a917ca881b22f6d55d1b955f0\"},\"headline\":\"More states consider dropping GLP-1 weight loss drugs from Medicaid\",\"datePublished\":\"2026-05-01T15:26:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/\"},\"wordCount\":426,\"publisher\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/DSC_0355-1024x683-1-pECXJA.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/\",\"url\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/\",\"name\":\"More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/DSC_0355-1024x683-1-pECXJA.jpg\",\"datePublished\":\"2026-05-01T15:26:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/DSC_0355-1024x683-1-pECXJA.jpg\",\"contentUrl\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/DSC_0355-1024x683-1-pECXJA.jpg\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/2026\\\/05\\\/01\\\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/westplexnews.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"More states consider dropping GLP-1 weight loss drugs from Medicaid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#website\",\"url\":\"https:\\\/\\\/westplexnews.com\\\/\",\"name\":\"WestplexNews.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/westplexnews.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#organization\",\"name\":\"WestplexNews.com\",\"url\":\"https:\\\/\\\/westplexnews.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png\",\"contentUrl\":\"https:\\\/\\\/westplexnews.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png\",\"width\":690,\"height\":242,\"caption\":\"WestplexNews.com\"},\"image\":{\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/westplexnews.com\\\/#\\\/schema\\\/person\\\/86ac6e2a917ca881b22f6d55d1b955f0\",\"name\":\"Brad Hildebrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g\",\"caption\":\"Brad Hildebrand\"},\"sameAs\":[\"http:\\\/\\\/Westplexnews.com\"],\"url\":\"https:\\\/\\\/westplexnews.com\\\/index.php\\\/author\\\/bradh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/","og_locale":"en_US","og_type":"article","og_title":"More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com","og_description":"A woman takes out an Ozempic pen. More states are considering dropping GLP-1 drugs from their Medicaid programs. (Photo by Shalina Chatlani\/Stateline) Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications.\u00a0 Thirteen state Medicaid programs...","og_url":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/","og_site_name":"WestplexNews.com","article_published_time":"2026-05-01T15:26:59+00:00","og_image":[{"url":"https:\/\/missouriindependent.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1.jpg","type":"","width":"","height":""}],"author":"Brad Hildebrand","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Brad Hildebrand","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#article","isPartOf":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/"},"author":{"name":"Brad Hildebrand","@id":"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0"},"headline":"More states consider dropping GLP-1 weight loss drugs from Medicaid","datePublished":"2026-05-01T15:26:59+00:00","mainEntityOfPage":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/"},"wordCount":426,"publisher":{"@id":"https:\/\/westplexnews.com\/#organization"},"image":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#primaryimage"},"thumbnailUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1-pECXJA.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/","url":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/","name":"More states consider dropping GLP-1 weight loss drugs from Medicaid - WestplexNews.com","isPartOf":{"@id":"https:\/\/westplexnews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#primaryimage"},"image":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#primaryimage"},"thumbnailUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1-pECXJA.jpg","datePublished":"2026-05-01T15:26:59+00:00","breadcrumb":{"@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#primaryimage","url":"https:\/\/westplexnews.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1-pECXJA.jpg","contentUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2026\/05\/DSC_0355-1024x683-1-pECXJA.jpg","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/westplexnews.com\/index.php\/2026\/05\/01\/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/westplexnews.com\/"},{"@type":"ListItem","position":2,"name":"More states consider dropping GLP-1 weight loss drugs from Medicaid"}]},{"@type":"WebSite","@id":"https:\/\/westplexnews.com\/#website","url":"https:\/\/westplexnews.com\/","name":"WestplexNews.com","description":"","publisher":{"@id":"https:\/\/westplexnews.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/westplexnews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/westplexnews.com\/#organization","name":"WestplexNews.com","url":"https:\/\/westplexnews.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/","url":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png","contentUrl":"https:\/\/westplexnews.com\/wp-content\/uploads\/2025\/06\/cropped-Westplex-News-MASTER-PNG-CLEAR-CROP-690-X-242.png","width":690,"height":242,"caption":"WestplexNews.com"},"image":{"@id":"https:\/\/westplexnews.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/westplexnews.com\/#\/schema\/person\/86ac6e2a917ca881b22f6d55d1b955f0","name":"Brad Hildebrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc2f8931c569b15114c958f40a15bda5a2ae504b7f31d3ecf1c2227aa19e0071?s=96&d=mm&r=g","caption":"Brad Hildebrand"},"sameAs":["http:\/\/Westplexnews.com"],"url":"https:\/\/westplexnews.com\/index.php\/author\/bradh\/"}]}},"_links":{"self":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts\/9616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/comments?post=9616"}],"version-history":[{"count":0,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/posts\/9616\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/media\/9617"}],"wp:attachment":[{"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/media?parent=9616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/categories?post=9616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/westplexnews.com\/index.php\/wp-json\/wp\/v2\/tags?post=9616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}